Presentation Descriptions



Sunday, June 9, 2019, 8:00 am – 12:00 pm
Travel Medicine and Working Overseas
Henry Wu, MD, Director, Emory TravelWell Center This program will consist of four sessions: General travel medicine, vaccines, working overseas, and case studies. Key preventative and safety topics for international travel, including risk assessment and the nuts and bolts of the pre-travel consultation visit will be covered. Details regarding travel immunizations and prophylaxis will be explored, including yellow fever, rabies, cholera, Japanese encephalitis, hepatitis, HIV kits, malaria prevention, and more. Session three will focus on preparing travelers with unique risks including long-term expatriates and those conducting research and/or providing healthcare services abroad. Special situations, such as pregnancy, animal bites, and emergency evacuations will be discussed. The course will conclude with case studies from the instructor’s experiences as a travel physician and expatriate.
Sunday, June 9, 2019, 1:00 pm – 5:00 pm
Occupational Medical Surveillance and Programs for Biological and Laboratory Animal Research
Gary Fujimoto, MD, Physician/Occupational Medicine Consultant This newly revised introductory course on medical surveillance will include updated information on how medical surveillance can be performed without the need for routine physical examinations. In addition, updated information on pro-active preventive measures for laboratory and lab animal staff will be presented. Discussion will include how to address infectious disease issues so that monitoring can be initiated without known or defined exposures. Information on the new hepatitis B vaccine along with issues with anesthetic gases, humanized animals and non-human primate work will be reviewed. This course offers time to discuss specific issues on laboratory medicine not covered in the presentation and encourages group discussions.
Monday, June 10, 2019, 8:00 am – 5:00 pm
Case Study: Management of Clinical Exposures to a Human Rabies Infection
Amy Behrman, MD, FACP, FACOEM, Director, Occupational Medicine Services, University of Pennsylvania After prolonged ICU admission, a patient was diagnosed with domestically acquired human rabies infection. More than 200 clinical staff were counseled and evaluated for potentially significant exposure using a modified CDC risk assessment tool combined with targeted in-person interviews. The session will cover hazard communication, risk assessment, post-exposure prophylaxis and infection control practices.
Case Study: Laboratory Animal Allergy Part I. Prevention of Laboratory Animal Allergy
Gregg M. Stave, MD, JD, MPH, Professor, Duke University Medical Center Allergic reactions are among the most common conditions affecting the health of workers involved in the care and use of research animals. This presentation will review the cause of symptoms and examine approaches to addressing respiratory allergy and anaphylaxis.
Part II. Collaborative Management and Continual Improvement of a University Respiratory Protection Program
Rebecca Ann Lingenfelter, MSPH, Associate Biosafety Officer, University of Pittsburg Developing and maintaining effective respiratory protection programs for research environments, particularly for laboratory animal research, requires cooperation, communication, and support at an organizational level. Productive communication between Occupational Health, Environmental Health and Safety, and laboratory animal research experts, as well as research faculty and staff, is critical for implementing and maintaining an effective program.
Part III. Occupational Health and Veterinary Perspectives
  Yolanda Lang, DNP, APRN-BC, COHN-S, Conway Medical Center; Tim Mandrell, DVM, DACLAM, Consultant
Viral Vectors: New Frontiers in Medicine
Gary Fujimoto, MD, Physician/Occupational Medicine Consultant
This presentation will cover some of the major advances made with viral vector technology in recent breakthroughs in medicine. These include exciting developments in gene transfer and chimeric antigen receptor T cell therapy (CART). While some of these approved technologies have involved lentiviral and retroviral vectors, a great deal of research has included adenoviral and adeno-associated viral vectors. These vector systems will be reviewed along with some of the diseases targeted by these systems.
Update on Important Global Infectious Disease Outbreaks
Lewis A. Hofmann, MD, FAAFP, Medical Director, Shoreland This presentation will bring together up-to-date information related to the most important global infectious disease outbreaks in the summer of 2019. The disease itself, status of the outbreak, current mitigation, actions for travelers, and future outlook will be reviewed for each.
Stories of Impact
Tuesday, June 11, 2019, 8:00 am – 3:00 pm
Occupational Health and Safety Concerns when working with MPTP
Serge Przedborski, MD, PhD, Columbia University Dr. Przedborshi pioneered the investigation of molecular mechanisms of neuronal death in the MPTP model of Parkinson’s disease (PD). MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is a potent neurotoxin known to produce severe irreversible brain damage similar to Parkinson’s disease. Exposure to MPTP through inhalation, dermal contact or injection is a potential hazard to humans work with the chemical. Working with MPTP requires strict adherence to safety precautions, practices and PPE. Dr. Przedborshi will outline the safety precautions and post exposure practices that he has developed for this research.
Interferon Gamma Release Assays for TB: Indications, Interpretations and Inferences
Sarah Foster-Chang, DNP, APRN-BC, COHN-S, Nurse Practitioner, Veterans Health Administration Screening for Tuberculosis (TB) has seen unprecedented changes with the introduction of Interferon Gamma Release Assays (IGRA). The new Centers for Disease Control and Prevention (CDC) guidelines regarding TB screening of healthcare workers will be reviewed. Using one facility’s transition from the traditional TB skin testing to an IGRA based program, the clinical characteristics and interpretational challenges of all the available screening tests for TB infection will be discussed. An overview of current research and knowledge gaps related to the use of IGRA’s will round out the session.
Case Study: Evaluation of Waste Isoflurane Exposures During Animal and Human Surgery
Derek A. Newcomer, DrPH, CIH, CSP, NIH/OD/ORS Prolonged occupational exposure to trace waste anesthetic gases may have potential adverse health effects. Workplace surveillance programs are intended to reduce health risk by evaluating exposures to waste anesthetic gases during surgical procedures. The aim of this study was to evaluate a waste anesthetic gas surveillance program to understand occupational exposures and further improve the data collection strategy. The study also evaluated relationship between waste anesthetic gas concentrations and type of instrument used for measurement, location of measurement, patient undergoing surgery, and scavenging method. Discussion will describe common waste management practices and opportunities to improve surveillance programs to minimize occupational exposures to waste anesthetic gases.
A Series of Unfortunate Events: Lesson Learned from Case Studies of Potential Exposures in Biological Laboratories
David Harbourt, PhD, CBSP, Biosafety Officer, USAMRIID This session is intended to cover some basic information of emergency response situations along with the occupational health considerations for affected personnel during an emergency. This session will go over the key aspects of a proper response and communication strategy as well as potential viability of quick response efforts within a laboratory prior to the arrival of emergency response personnel. The session will also detail some real-world emergency events that occurred how the safety and leadership staff responded along with lessons learned related to their responses.
Tuesday, June 11, 2019, 3:00 pm – 6:00 pm
Developing a Resource Library – Protocols, Templates, and Tools (Oh My!)
Julie Fischer, PhD, Director, Center for Global Health Science and Security, Georgetown University Medical School This optional workshop is an opportunity for interested Colloquium participants to discuss the possibilities, processes, requirements, and risks for creating an online repository of tools and protocols developed for occupational health and biosafety programs. The goal is to develop a library of resources under the stewardship of the Elizabeth R. Griffin Program to share tested protocols and best practices. This planning meeting is an opportunity to shape the framework for how best to peer-review, anonymize, protect, and share these resources.
Wednesday, June 12, 2019, 8:00 am – 12:00 pm
Occupational Health and Safety in Animal Programs: An Overview and Case Study
Helen Diggs, MEd, DVM, DACLAM, Senior Director, AAALAC International; John N. Norton, DVM, PhD, DABT, DACLAM During AAALAC site visits of animal facilities and programs, deficiencies are frequently found involving occupational health and safety. Prevent this from happening at your institution! This workshop will combine an AAALAC site visitor’s perspective with a facility director’s experiences. Dr. Diggs will present AAALAC International’s expectations for Occupational Health and Safety Programs, and Dr. Norton will follow-up with a “recipe for success” for implementing these expectations in an animal program. Best practices based on the “Eighth Edition of the Guide for the Care and Use of Laboratory Animals” will be explored.